McBurney M I
Department of Foods and Nutrition, University of Alberta, Edmonton, Canada.
Nutrition. 1991 Nov-Dec;7(6):421-4.
Liquid enteral diets supplemented with dietary fiber, typically soy fiber, are in widespread use to increase stool bulking and maintain gastrointestinal function. Yeast cells, containing beta-glucans, represent another commercially available fiber source that could be added to enteral diets. The objective of this study was to compare commercially available purified fiber sources, i.e., mixed fiber (Fibrad), psyllium hydrocolloid (Metamucil), and yeast cell walls (Fibercel), for potential use in liquid diets in terms of potential water-holding capacity (PWHC) and SCFA production (mmol SCFA/g organic matter [OM]). Fiber samples were fermented in vitro with human fecal microbiota from three donors for 24 h, and SCFA production was greatest from beta-glucan (8.24 mmol/g OM), followed by psyllium (5.57 mmol/g OM) and mixed fiber (4.50 mmol/g OM) (p less than 0.0001). WHCs of the original materials (g H2O/g OM) differed (p less than 0.02) at 4.59, 5.79, and 8.63 for beta-glucan, mixed fiber, and psyllium, respectively. PWHC (g H2O/g OM), an in vitro measure of stool bulking, differed (p less than 0.0001) with psyllium (4.48) greater than mixed fiber (3.52) greater than beta-glucan (2.22). These three fiber systems appear to have distinctly different physiological effects in vivo. Of the three products, mixed fiber was the most inert. Psyllium seems to enhance both SCFA production and stool bulk relative to mixed fiber, whereas beta-glucan most significantly increases SCFA production with a minimal effect on stool bulk.
补充膳食纤维(通常为大豆纤维)的液体肠内营养制剂被广泛用于增加粪便体积并维持胃肠功能。含有β-葡聚糖的酵母细胞是另一种可添加到肠内营养制剂中的商业可用纤维来源。本研究的目的是比较市售的纯化纤维来源,即混合纤维(Fibrad)、车前子亲水胶体(Metamucil)和酵母细胞壁(Fibercel),就潜在持水能力(PWHC)和短链脂肪酸产生量(每克有机物质[OM]产生的短链脂肪酸毫摩尔数)而言,在液体营养制剂中的潜在用途。将纤维样品与来自三名供体的人类粪便微生物群在体外发酵24小时,β-葡聚糖产生的短链脂肪酸最多(8.24 mmol/g OM),其次是车前子(5.57 mmol/g OM)和混合纤维(4.50 mmol/g OM)(p<0.0001)。β-葡聚糖、混合纤维和车前子的原材料持水能力(克水/克OM)分别为4.59、5.79和8.63,存在差异(p<0.02)。作为粪便体积体外测量指标的PWHC(克水/克OM)也存在差异(p<0.0001),车前子(4.48)大于混合纤维(3.52)大于β-葡聚糖(2.22)。这三种纤维系统在体内似乎具有明显不同的生理作用。在这三种产品中,混合纤维最不活跃。与混合纤维相比,车前子似乎既能促进短链脂肪酸的产生又能增加粪便体积,而β-葡聚糖最显著地增加短链脂肪酸的产生,对粪便体积的影响最小。